Back to search

Netherlands· NL-d8725768f777

Colestyramine suikervrij 4 g Focus, poeder voor orale suspensie

A colestyramine product containing colestyramine, registered in Netherlands by Focus Care Pharmaceuticals B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC C10AC01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedColestyramine suikervrij 4 g Focus, p…ATCC10AC01REGISTER NO.NL-d8725768f777PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Colestyramine is registered in 13 of 19 countries.

Countries holding a registration under ATC C10AC01 (colestyramine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Colestyramine · ATC C10AC01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
COLESTYRAMINE
Manufacturer
Focus Care Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
C10AC01
ATC class
Colestyramine
Defined daily dose
14 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    124229

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

88 interactions on record for colestyramine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Colestyramine · interactions on record

88 records

  • 3 severe
  • 73 moderate
  • 7 minor

Most severe, free to view

  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • TeriflunomideL04AK02severe
  • Chenodeoxycholic acidA05AA01moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colestyramine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colestyramine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Quantalan Zuckerfrei
  • Belgium · Questran
  • Cyprus · Resincolestiramina
  • Germany · Colestyramin 1 A Pharma, Colestyramin Ratiopharm
  • Denmark · Colestyramin Orifarm
  • Spain · Efensol, Resincolestiramina
  • Finland · Questran
  • France · Questran
  • United Kingdom (Northern Ireland) · Colestyramine Light Laboratorios Rubió, Colestyramine Neon Healthcare
  • Hungary · Cholestyramine
  • Ireland · Questran
  • Italy · Questran
  • Luxembourg · Questran
  • Norway · Questran, Questran Loc
  • Portugal · Quantalan
  • Sweden · Kolestyramin Alternova, Questran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/005252d6-b4f9-45b5-b8b9-bd7d91584d61
GET /v1/drugs/005252d6-b4f9-45b5-b8b9-bd7d91584d61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor orale suspensie",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124229_smpc.pdf",
  "strength": null,
  "atc_label": "Colestyramine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124229",
  "excipients": [
    "ARABISCHE GOM (E 414)",
    "ASPARTAAM (E 951)",
    "BUTYLHYDROXYANISOL (E 320)",
    "CITROENZUUR 0-WATER (E 330)",
    "MALTODEXTRINE",
    "NATUURLIJK SINAASAPPELSMAAKSTOF PDR 20.4562.4P PHA",
    "NATUURLIJKE EN KUNSTMATIGE SMAAKSTOFFEN",
    "PROPYLEENGLYCOLALGINAAT (E 405)",
    "SILICIUMDIOXIDE (E 551)",
    "XANTHAANGOM (E 415)",
    "ZONNEGEEL FCF (E 110)"
  ],
  "substances": [
    "COLESTYRAMINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124229.pdf",
  "authorised_at": "2020/01/06",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "124229",
  "additional_monitoring": "N"
}

See everything about colestyramine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.